Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Diabetes, Obesity and Metabolism
Published October 20, 2026
Efficacy and Feasibility of Just-in-Time Nudging in Reducing Evening Snacking Measured by Continu...
October 21, 2026
Medspoke
Medspoke
Blood
Published October 19, 2026
00:00
--:--
A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly dia...
October 20, 2026
Share
A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.
https://www.medspoke.co/channel_journal?id=683&tap_id=15959
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood
Published October 19, 2026
A new reporter strategy reveals a subset of nonmigratory hematopoietic stem cells located in a dy...
October 20, 2026
Why are you reporting this TALK?
